|
09/13/2006, 10:00 AM - 10:45 AM
Speakers:
Aaron Kitzmiller, Manager, Analysis Development and Application, Wyeth Research.
Ian Penny, Pfizer.
Stephan Ogenstad, President, STATOGEN consulting.
Grid computing is a technology that enables efficient simulation to allow more analysis in the virtual world in less time, thereby, reducing time to market and development costs for many industry segments. Organizations in the pharmaceutical industry have quickly realized how grid computing can help them reduce drug development costs, as well as, the time it takes to develop more individually targeted treatment solutions. Among other things, grid computing is allowing the pharma industry to increase clinical trial success rates through clinical trial simulation, raise the quality of development and manufacturing processes, deliver greater returns to their shareholders, and drive breakthrough growth. Join several leaders in the pharma industry in a discussion of the successes, benefits of, and lessons learned using grid computing in their organizations. As a result, learn how you can leverage grid computing in your own enterprise.
|
